Skip to main content
Caplight Logo









AMO Pharma

AMO Pharma

Private
LeedsHealthcare & Life Scienceshttps://amo-pharma.com/

Last Round

Private Equity

Dec 6, 2022

Total Funding Raised

$25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AMO Pharma is a biopharmaceutical company that develops treatments for serious and debilitating rare genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalrare diseaseorphan drugclinical trialssmall-molecule therapypediatric medicineneurodevelopmental disordersdrug developmentneuromuscular disordersbiotechclinical-stage biotechdrug pipelinepharmacological intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMO Pharma Comparables

Compare AMO Pharma with similar companies based on industry and business-model similarity.

AMO Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuren Pharmaceuticals Limited
80%
Novartis
78%
Connecta Therapeutics
78%

AMO Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityDec 6, 2022
Private EquityMay 10, 2022
VC RoundJan 9, 2020
Private EquitySep 30, 2015

AMO Pharma Investors

Notable investors and investment history

AMO Pharma investors
InvestorRounds
Woodford Investment ManagementPrivate Equity
Woodford Patient Capital TrustPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 39% MoM to 5.2K.

  • Jun 1, 2025

    Monthly visitors increased 90% MoM.

AMO Pharma Filings

Explore SEC and related filing metadata, where available.

AMO Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AMO Pharma's valuation, stock price, and market status.

Is AMO Pharma a public or private company?

AMO Pharma is a private company.

What is the current stock price of AMO Pharma?

AMO Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is AMO Pharma worth (valuation)?

Valuation information for AMO Pharma is not publicly available.

Can I buy AMO Pharma stock?

AMO Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AMO Pharma's last funding round?

AMO Pharma's most recent funding round was Private Equity on December 6, 2022.

Who are the main investors in AMO Pharma?

Key investors in AMO Pharma include Woodford Investment Management.

Will AMO Pharma IPO soon?

No public IPO plans have been announced for AMO Pharma.

How can I track AMO Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMO Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeeds
Employee Range6
Year Founded2014
Last FundingDec 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?